5-HT_2A and 5-HT₃ receptors contribute to the exacerbation of targeted and non-targeted effects of ionizing radiation-induced cell death in human colon carcinoma cells

References

• Azzam EI, de Toledo SM, Little JB. 2003. Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect. Oncogene. 22(45):7050–7057.
   PubMed Web of Science ®Google Scholar
• Blum RA, Majumdar A, McCrea J, Busillo J, Orlowski LH, Panebianco D, Hesney M, Petty KJ, Goldberg MR, Murphy MG, et al. 2003. Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. Clin Ther. 25(5):1407–1419.
   PubMed Web of Science ®Google Scholar
• Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F. 2007. Plasma serotonin levels and the platelet serotonin transporter. J Neurochem. 102(1):206–215.
   PubMed Web of Science ®Google Scholar
• Chapman KL, Al-Mayah AH, Bowler DA, Irons SL, Kadhim MA. 2012. No influence of serotonin levels in foetal bovine sera on radiation-induced bystander effects and genomic instability. Int J Radiat Biol. 88(10):781–785.
   PubMed Web of Science ®Google Scholar
• Curtis JJ, Seymour CB, Mothersill CE. 2018. Cell line-specific direct irradiation and bystander responses are influenced by fetal bovine serum serotonin concentrations. Radiat Res. 190(3):262–270.
   PubMed Web of Science ®Google Scholar
• Fazzari J, Mersov A, Smith R, Seymour C, Mothersill C. 2012. Effect of 5-hydroxytryptamine (serotonin) receptor inhibitors on the radiation-induced bystander effect. Int J Radiat Biol. 88(10):786–790.
   PubMed Web of Science ®Google Scholar
• Häfner MF, Debus J. 2016. Radiotherapy for colorectal cancer: current standards and future perspectives. Visc Med. 32(3):172–177.
   PubMed Web of Science ®Google Scholar
• Hedner T, Persson B, Berglund G. 1983. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol. 16(2):121–125.
   PubMed Web of Science ®Google Scholar
• Hervé P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. 1995. Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 99(3):249–254.
   PubMed Web of Science ®Google Scholar
• Hope AG, Peters JA, Brown AM, Lambert JJ, Blackburn TP. 1996. Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-As) subunit stably expressed in HEK 293 cells. Br J Pharmacol. 118(5):1237–1245.
   PubMed Web of Science ®Google Scholar
• Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46(2):157–203.
   PubMed Web of Science ®Google Scholar
• Igarashi M, Okuda T, Oh-i T, Koga M. 2000. Changes in plasma serotonin concentration and acceleration plethysmograms in patients with Raynaud’s phenomenon after long-term treatment with a 5-HT2 receptor antagonist. J Dermatol. 27(10):643–650.
   PubMedGoogle Scholar
• Jungwirth N, Haeberle L, Schrott KM, Wullich B, Krause FS. 2008. Serotonin used as prognostic marker of urological tumors. World J Urol. 26(5):499–504.
   PubMed Web of Science ®Google Scholar
• Kalanxhi E, Dahle J. 2012. The role of serotonin and p53 status in the radiation-induced bystander effect. Int J Radiat Biol. 88(10):773–776.
   PubMed Web of Science ®Google Scholar
• Klammer H, Iliakis G. 2012. The impact of serotonin on the development of bystander damage assessed by γ-H2AX foci analysis. Int J Radiat Biol. 88(10):777–780.
   PubMed Web of Science ®Google Scholar
• Le M, Fernandez-Palomo C, McNeil FE, Seymour CB, Rainbow AJ, Mothersill CE. 2017. Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: reconciling the mechanisms mediated the bystander effect. PLoS One. 12(3):e0173685.
   PubMed Web of Science ®Google Scholar
• Lyng FM, Desplanques M, Jella KK, Garcia A, McClean B. 2012. The importance of serum serotonin levels in the measurement of radiation-induced bystander cell death in HaCaT cells. Int J Radiat Biol. 88(10):770–772.
   PubMed Web of Science ®Google Scholar
• Lyng FM, Maguire P, McClean B, Seymour C, Mothersill C. 2006. The involvement of calcium and MAP kinase signaling pathways in the production of radiation-induced bystander effects. Radiat Res. 165(4):400–409.
   PubMed Web of Science ®Google Scholar
• Marín A, Martín M, Liñán O, Alvarenga F, López M, Fernández L, Büchser D, Cerezo L. 2015. Bystander effects and radiotherapy. Rep Pract Oncol Radiother. 20(1):12–21.
   PubMedGoogle Scholar
• Mothersill C, Antonelli F, Dahle J, Dini V, Hegyesi H, Iliakis G, Kämäräinen K, Launonen V, Lumniczky K, Lyng F, et al. 2012. A laboratory inter-comparison of the importance of serum serotonin levels in the measurement of a range of radiation-induced bystander effects: overview of study and results presentation. Int J Radiat Biol. 88(10):763–769.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Bristow RG, Harding SM, Smith RW, Mersov A, Seymour CB. 2011. A role for p53 in the response of bystander cells to receipt of medium borne signals from irradiated cells. Int J Radiat Biol. 87(11):1120–1125.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Saroya R, Smith RW, Singh H, Seymour CB. 2010. Serum serotonin levels determine the magnitude and type of bystander effects in medium transfer experiments. Radiat Res. 174(1):119–123.
   PubMed Web of Science ®Google Scholar
• Mothersill C, Seymour CB. 2004. Radiation-induced bystander effects – implications for cancer. Nat Rev Cancer. 4(2):158–164.
   PubMed Web of Science ®Google Scholar
• Nichols DE, Nichols CD. 2008. Serotonin receptors. Chem Rev. 108(5):1614–1641.
   PubMed Web of Science ®Google Scholar
• Odaka Y, Takahashi J, Tsuburaya R, Nishimiya K, Hao K, Matsumoto Y, Ito K, Sakata Y, Miyata S, Manita D, et al. 2017. Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries. Eur Heart J. 38(7):489–496.
   PubMed Web of Science ®Google Scholar
• Persson B, Hedner T, Berglund G. 1983. Ketanserin in essential hypertension: effects during rest and exercise. Eur J Clin Pharmacol. 25(3):307–312.
   PubMed Web of Science ®Google Scholar
• Pinho C, Wong R, Sur RK, Hayward JE, Farrell TJ, Seymour C, Mothersill C. 2012. The involvement of serum serotonin levels producing radiation-induced bystander effects for an in vivo assay with fractionated high dose-rate (HDR) brachytherapy. Int J Radiat Biol. 88(10):791–797.
   PubMed Web of Science ®Google Scholar
• Poon RCC, Agnihotri N, Seymour C, Mothersill C. 2007. Bystander effects of ionizing radiation can be modulated by signaling amines. Environ Res. 105(2):200–211.
   PubMed Web of Science ®Google Scholar
• Prise KM, O’Sullivan JM. 2009. Radiation-induced bystander signaling in cancer therapy. Nat Rev Cancer. 9(5):351–360.
   PubMed Web of Science ®Google Scholar
• Puck TT, Marcus PI. 1956. Action of X-rays on mammalian cells. J Exp Med. 103(5):653–666.
   PubMed Web of Science ®Google Scholar
• Rashid M, Manivet P, Nishio H, Pratuangdejkul J, Rajab M, Ishiguro M, Launay JM, Nagatomo T. 2003. Identification of binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling. Life Sci. 73(2):193–207.
   PubMed Web of Science ®Google Scholar
• Saroya R, Smith R, Seymour C, Mothersill C. 2010. Injection of resperpine into zebrafish, prevents fish to fish communication of radiation-induced bystander signals: confirmation in vivo of a role for serotonin in the mechanism. Dose Response. 8(3):317–330.
   Web of Science ®Google Scholar
• Sarrouilhe D, Mesnil M. 2019. Serotonin and human cancer: a critical view. Biochimie. 161:46–50.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Plummer R, Stock JK, Greenhalgh TA, Ataman O, Kelly S, Clay R, Adams RA, Baird RD, Billingham L, et al. 2016. Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol. 13(10):627–642.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin. 65(1):5–29.
   PubMed Web of Science ®Google Scholar
• Steegmans PH, Fekkes D, Hoes AW, Bak AA, van der Does E, Grobbee DE. 1996. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 312(7025):221.
   PubMedGoogle Scholar
• Tofilon PJ, Saxman S, Coleman CN. 2003. Molecular targets for radiation therapy: bringing preclinical data into clinical trials. Clin Cancer Res. 9(10 Pt 1):3518–3520.
   PubMed Web of Science ®Google Scholar
• Xia Y, Wang D, Zhang N, Wang Z, Pang L. 2018. Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients. J Clin Lab Anal. 32(2):e22263.
   Web of Science ®Google Scholar